Target Price | $140.05 |
Price | $113.69 |
Potential | 23.19% |
Number of Estimates | 20 |
20 Analysts have issued a price target Merck & Co. 2025 . The average Merck & Co. target price is $140.05. This is 23.19% higher than the current stock price. The highest price target is $155.00 36.34% , the lowest is $125.00 9.95% . | |
A rating was issued by 26 analysts: 23 Analysts recommend Merck & Co. to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Merck & Co. stock has an average upside potential 2025 of 23.19% . Most analysts recommend the Merck & Co. stock at Purchase. |
19 Analysts have issued a sales forecast Merck & Co. 2024 . The average Merck & Co. sales estimate is $64.1b . This is 3.03% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $64.4b 3.61% , the lowest is $63.4b 1.95% .
This results in the following potential growth metrics:
2023 | $59.9b | 2.39% |
---|---|---|
2024 | $64.1b | 7.01% |
2025 | $68.1b | 6.36% |
2026 | $72.2b | 5.97% |
2027 | $74.8b | 3.61% |
2028 | $75.2b | 0.51% |
12 Analysts have issued an Merck & Co. EBITDA forecast 2024. The average Merck & Co. EBITDA estimate is $27.9b . This is 38.13% higher than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $30.0b 48.48% , the lowest is $26.4b 30.48% .
This results in the following potential growth metrics and future EBITDA Margins:
2023 | $6.9b | 70.72% |
---|---|---|
2024 | $27.9b | 307.47% |
2025 | $32.3b | 15.52% |
2026 | $34.5b | 6.80% |
2027 | $36.8b | 6.75% |
2028 | $37.2b | 1.21% |
2023 | 11.45% | 71.41% |
---|---|---|
2024 | 43.59% | 280.77% |
2025 | 47.34% | 8.60% |
2026 | 47.71% | 0.78% |
2027 | 49.16% | 3.04% |
2028 | 49.50% | 0.69% |
10 Merck & Co. Analysts have issued a net profit forecast 2024. The average Merck & Co. net profit estimate is $19.1b . This is 39.78% higher than the net profit for the last 12 months(TTM). The highest net profit forecast is $20.4b 48.89% , the lowest is $17.9b 30.93% .
This results in the following potential growth metrics and future Net Margins:
2023 | $355m | 97.55% |
---|---|---|
2024 | $19.1b | 5,291.43% |
2025 | $23.2b | 21.31% |
2026 | $25.4b | 9.51% |
2027 | $26.7b | 4.96% |
2028 | $27.2b | 2.01% |
2023 | 0.59% | 97.61% |
---|---|---|
2024 | 29.87% | 4,937.72% |
2025 | 34.07% | 14.06% |
2026 | 35.21% | 3.35% |
2027 | 35.67% | 1.31% |
2028 | 36.20% | 1.49% |
10 Analysts have issued a Merck & Co. forecast for earnings per share. The average Merck & Co. <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is $7.55 . This is 39.81% higher than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is $8.04 48.89% , the lowest is $7.07 30.93% .
This results in the following potential growth metrics and future valuations:
2023 | $0.14 | 97.55% |
---|---|---|
2024 | $7.55 | 5,292.86% |
2025 | $9.16 | 21.32% |
2026 | $10.03 | 9.50% |
2027 | $10.52 | 4.89% |
2028 | $10.74 | 2.09% |
Current | 21.07 | 75.94% |
---|---|---|
2024 | 15.06 | 28.52% |
2025 | 12.42 | 17.53% |
2026 | 11.34 | 8.70% |
2027 | 10.80 | 4.76% |
2028 | 10.59 | 1.94% |
Based on analysts' sales estimates for 2024, the Merck & Co. stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of 4.91 and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of 4.50 .
This results in the following potential growth metrics and future valuations:
Current | 5.06 | 3.44% |
---|---|---|
2024 | 4.91 | 2.94% |
2025 | 4.62 | 5.98% |
2026 | 4.36 | 5.63% |
2027 | 4.21 | 3.48% |
2028 | 4.18 | 0.51% |
Current | 4.63 | 1.50% |
---|---|---|
2024 | 4.50 | 2.94% |
2025 | 4.23 | 5.98% |
2026 | 3.99 | 5.64% |
2027 | 3.85 | 3.48% |
2028 | 3.83 | 0.51% |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.